Add BrightSurf on Google Email

NEW STUDY: Discovery of chemical means to reverse aging and restore cellular function

A team of scientists at Harvard Medical School has identified six chemical cocktails that can restore cellular aging and rejuvenate human cells. The study builds upon the discovery of Yamanaka factors, which can convert adult cells into induced pluripotent stem cells, raising hopes for treating age-related diseases and injuries. The im...

SourceImpact Journals LLC·JournalAging-US·TypeExperimental study·DateJul 12, 2023

New understanding of why kidney cancers become metastatic discovered by MD Anderson researchers

Researchers at MD Anderson Cancer Center have engineered a new model of aggressive renal cell carcinoma, highlighting molecular targets and genomic events that trigger chromosomal instability. The loss of interferon receptor genes plays a pivotal role in allowing cancer cells to become tolerant of chromosomal instability.

Innovative gene therapy may help treat a severe and fatal developmental epilepsy syndrome that affects children

Researchers at Tel Aviv University have developed an innovative gene therapy that shows promise in treating Dravet syndrome, a severe developmental epilepsy affecting children. The treatment was found to be effective in improving epilepsy, protecting against early death, and enhancing cognitive abilities.

SourceTel-Aviv University·JournalJournal of Clinical Investigation·DateJun 22, 2023

Can light therapy treat atrial fibrillation?

New research suggests optogenetics could restore regular heart rhythm without shocks, improving prognosis and quality of life for AF patients. Light therapy has shown promising results in rats, indicating potential translatability to humans.

SourceWiley·JournalJournal of Internal Medicine·DateJun 21, 2023

Pro-viral human protein critical for embryo development

Researchers discovered that ZC3H11A is essential for regulating metabolic genes in embryos and their absence leads to complete lethality. The study's findings suggest that ZC3 may be a promising therapeutic target for the development of anti-viral agents against medically significant human viruses.

SourceUppsala University·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateMay 31, 2023

Study finds similar quality and cost of care for patients treated by an allopathic (M.D.) or osteopathic (D.O.) physician

An observational study of 329,000 Medicare admissions found that older persons receiving hospital care from allopathic (M.D.) or osteopathic (D.O.) physicians experience similar quality and cost of care. Researchers also highlight systemic health inequities faced by persons with sickle cell disease.

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·TypeData/statistical analysis·DateMay 29, 2023

Gene therapy rescues hearing for the first time in aged mouse models

Researchers successfully demonstrate AAV vector efficacy in aged animal models, showing robust hearing rescue in mice with a mutation equivalent to a defective human gene. The study suggests that virally mediated gene therapy could potentially treat genetic hearing loss, especially for patients diagnosed at advanced age.

SourceMass Eye and Ear·JournalMolecular Therapy·TypeComputational simulation/modeling·DateMay 26, 2023

Researchers overcome stem cell delivery barrier, paving the way for regenerative medicine

Scientists have developed a new method to deliver genetic information to stem cells using nanoparticles coated with a specific polymer, enabling more efficient control over cellular differentiation. This innovation has the potential to improve the efficiency and effectiveness of regenerative medicine treatments.

SourceXi'an Jiaotong-Liverpool University·JournalNano Letters·TypeExperimental study·DateMay 8, 2023

Bold new therapy delivery method shows initial promise as treatment for Duchenne muscular dystrophy

A new therapy delivery method, using modified viruses engineered with fusogens Myomaker and Myomerger, shows promise as a treatment for Duchenne muscular dystrophy. The vector can deliver a vital gene needed for muscle function to cells, potentially providing a lifelong supply of the missing gene.

SourceCincinnati Children's Hospital Medical Center·JournalCell·TypeExperimental study·DateApr 27, 2023

Mass Eye and Ear Hearing scientists use drug-like cocktail to regenerate hair cells in preclinical study

Researchers have created a drug-like cocktail that successfully regenerated hair cells in a mouse model by reprogramming genetic pathways within the inner ear. The approach could lead to clinical trials for a gene therapy that can be administered to people with hearing loss, potentially treating up to 90% of cases.

SourceMass Eye and Ear·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateApr 18, 2023

Benefiting from orphan drug and rare pediatric disease designations for gene therapy

The NCATS Platform Vector Gene Therapy (PaVe-GT) program utilizes FDA guidance to prepare applications for Orphan Drug Designation (ODD) and Rare Pediatric Disease Designation (RPDD), stimulating gene therapy development. The PaVe-GT program has already helped receive ODD and RPDD designations for a gene therapy product treating PCCA-r...

SourceMary Ann Liebert, Inc./Genetic Engineering News·JournalHuman Gene Therapy·TypeExperimental study·DateMar 27, 2023

Enabling adeno-associated virus gene therapy despite preexisting humoral immunity

Researchers used a monoclonal antibody to reduce circulating IgG levels, allowing for successful gene delivery to the liver and heart via systemic AAV-based gene therapy in mice and non-human primates. The strategy has potential to circumvent neutralizing antibody limitations and expand gene therapy accessibility.

SourceMary Ann Liebert, Inc./Genetic Engineering News·JournalHuman Gene Therapy·TypeExperimental study·DateMar 22, 2023

DART VADAR harnesses the force of enzymes for better RNA drugs

Researchers at Harvard University developed a novel RNA sense-and-respond circuit, DART VADAR, which utilizes an enzyme to detect specific molecular markers of disease and cell types. This enables highly specific treatments for various diseases by triggering the translation of therapeutic genetic payloads.

SourceWyss Institute for Biologically Inspired Engineering at Harvard·JournalNature Communications·TypeExperimental study·DateMar 20, 2023

UCLA-led study uses base editing to correct mutation that causes rare immune deficiency

Researchers at UCLA successfully used base editing to correct a mutation causing rare immune deficiency CD3 delta SCID. The treatment corrected an average of 71% of patient stem cells and allowed them to produce fully functional T cells, suggesting long-term persistence of corrected blood stem cells.

SourceUniversity of California - Los Angeles Health Sciences·JournalCell·TypeExperimental study·DateMar 20, 2023

Rice scientists reengineer cancer drugs to be more versatile

Researchers from Rice University have developed a new approach to control gene expression using proteolysis targeting chimeras (PROTACs). By reengineering the PROTAC molecular infrastructure, they demonstrated the ability to achieve chemically induced dimerization (CID), allowing for precise control over gene activation in specific loc...

SourceRice University·JournalJournal of the American Chemical Society·TypeExperimental study·DateFeb 14, 2023